Diastasis recti is associated with incisional hernia after midline abdominal surgery.

Autor: Booth AT; Department of Surgery, Medical University of South Carolina, 169 Ashley Avenue, Room 202, Charleston, SC, 29425, USA. boothal@musc.edu., Gillen KJ; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA., Visintin I; Department of Surgery, Medical University of South Carolina, 169 Ashley Avenue, Room 202, Charleston, SC, 29425, USA., Ford WF; Department of Surgery, Medical University of South Carolina, 169 Ashley Avenue, Room 202, Charleston, SC, 29425, USA., Kovacs MD; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA., Edgerton CA; Department of Surgery, Medical University of South Carolina, 169 Ashley Avenue, Room 202, Charleston, SC, 29425, USA., George VV; Department of Surgery, Medical University of South Carolina, 169 Ashley Avenue, Room 202, Charleston, SC, 29425, USA., Curran T; Department of Surgery, Medical University of South Carolina, 169 Ashley Avenue, Room 202, Charleston, SC, 29425, USA.

Publikováno v: Hernia : the journal of hernias and abdominal wall surgery [Hernia] 2023 Apr; Vol. 27 (2), pp. 363-371. Date of Electronic Publication: 2022 Sep 22.

The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent.

Autor: Ciniero G; PolitoBIOMedLab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.; Centre de Recherche en Cancérologie de Lyon, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Pedro TM; Centre de Recherche en Cancérologie de Lyon, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Dumontet C; Centre de Recherche en Cancérologie de Lyon, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Elmenoufy AH; Department of Chemistry, University of Alberta, Edmonton, AB, Canada.; Department of Pharmaceutical Chemistry, College of Pharmacy, Misr University for Science and Technology, 6th of October City, Egypt., West FG; Department of Chemistry, University of Alberta, Edmonton, AB, Canada.; Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB, Canada.; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Weinfeld M; Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB, Canada.; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Gentile F; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Canada.; Ottawa Institute of Systems Biology, Ottawa, Canada., Tuszynski JA; PolitoBIOMedLab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy., Cros-Perrial E; Centre de Recherche en Cancérologie de Lyon, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Jordheim LP; Centre de Recherche en Cancérologie de Lyon, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.

Publikováno v: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2024 Nov 08. Date of Electronic Publication: 2024 Nov 08.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF.

Autor: Chapman TM; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Wallace C; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Gillen KJ; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Bakrania P; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Khurana P; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Coombs PJ; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Fox S; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Bureau EA; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Brownlees J; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK., Melton DW; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, MRC Human Genetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK., Saxty B; Centre for Therapeutics Discovery, MRC Technology, 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, UK.

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2015 Oct 01; Vol. 25 (19), pp. 4104-8. Date of Electronic Publication: 2015 Aug 14.

Structure based evolution of a novel series of positive modulators of the AMPA receptor.

Autor: Jamieson C; Merck Research Laboratories, MSD, Newhouse, Motherwell, Lanarkshire ML1 5SH, UK. craig.jamieson@strath.ac.uk, Maclean JK, Brown CI, Campbell RA, Gillen KJ, Gillespie J, Kazemier B, Kiczun M, Lamont Y, Lyons AJ, Moir EM, Morrow JA, Pantling J, Rankovic Z, Smith L

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Jan 15; Vol. 21 (2), pp. 805-11. Date of Electronic Publication: 2010 Nov 25.